Stay updated on Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, signaling a new page revision. This appears to be a metadata update rather than a change to core content or user-facing features.
    Difference
    0.0%
    Check dated 2026-05-16T09:49:20.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A new citation to the 2026 JAMA Dermatology article by Yosipovitch et al. was added; the prior 2025 online-ahead-of-print citation in Dermatol Ther (Heidelb) was removed.
    Difference
    0.0%
    Check dated 2026-05-02T09:26:24.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The study’s Publications section now lists a newer/updated bibliographic version of the JAMA Dermatology LIBERTY-CSU CUPID phase 3 trial citation (with the final April issue details instead of the earlier online-ahead-of-print entry). The page header footer revision identifier was also updated (v3.5.3), reflecting a site update rather than study content.
    Difference
    0.1%
    Check dated 2026-04-25T05:09:19.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:33:48.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the page, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T03:08:13.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new publication citation is added to the Publications section: Gimenez-Arnau AM et al. Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naive Patients with Chronic Spontaneous Urticaria. Dermatol Ther (Heidelb). 2026 Jan;16(1):549-562 (doi:10.1007/s13555-025-01605-w; Epub 2025 Dec 2). The prior 2025 Dec 2 'Online ahead of print' entry is removed.
    Difference
    0.0%
    Check dated 2026-03-05T00:31:28.000Z thumbnail image

Stay in the know with updates to Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in CSU Patients Unresponsive to Omalizumab Clinical Trial page.